A STUDY TO ASSESS THE EFFECTIVENESS OF IMMUNRICH IN COVID 19 POSITIVE PATIENTS
Phase 2
- Conditions
- Health Condition 1: J988- Other specified respiratory disorders
- Registration Number
- CTRI/2020/12/029713
- Lead Sponsor
- RPS BIOTECH PVTLTD
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
2.RT-PCR Based Corona positive patient and
rapid antigen test
3.Consent to participate in the trial
Exclusion Criteria
1.Individual with uncontrolled unstable comorbidities
2.Individual with pre- existing respiratory conditions
3.Immunocompromised individuals or those on immunosuppressants
4.Patients on or requiring parenteral nutrition
5.Pregnant and lactating female
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1.Improvement in Bala of an individual <br/ ><br>2.Immuno- stimulation leading to non-development of Covid-19 in risk population exposed to infected individual <br/ ><br>Timepoint: <br/ ><br>assessment after 1 week <br/ ><br>1.Improvement in Bala of an individual <br/ ><br>2.Immuno- stimulation leading to non-development of Covid-19 in risk population exposed to infected individual <br/ ><br>
- Secondary Outcome Measures
Name Time Method IMPROVEMENT IN QUALITY OF LIFETimepoint: Assessment after 4 weeks <br/ ><br> <br/ ><br>IMPROVEMENT OF QUALITY OF LIFE